ClearNote Health
Biotechnology ResearchView the employees at
ClearNote Health-
Yuhong Ning Distinguished Computational Biologist at ClearNote Health - Precision Epigenomic Medicine
-
San Mateo, California, United States
-
Top 5%
Maryam Nabiyouni, PhD Lead Automation Scientist at ClearNote Health (formerly Bluestar Genomics)-
San Diego, California, United States
-
Top 5%
Anna Bergamaschi Vice President, Product Development at ClearNote Health (formerly Bluestar Genomics)-
San Diego, California, United States
-
Top 10%
Michael Kesling Bioinformatics Data Scientist at Bluestar Genomics-
San Francisco, California, United States
-
Top 5%
Micah Collins Manager - ClearNote Health (formerly Bluestar Genomics)-
San Diego, California, United States
-
Top 10%
Overview
ClearNote Health – Cancer detection company enabling people at risk for high-mortality cancers to live longer, healthier lives. We focus on developing non-invasive tests to detect cancer through a standard blood draw earlier than existing methods by harnessing the power of epigenomics. We apply our proprietary epigenomic platform, combining biology and artificial intelligence, to identify DNA-based changes in biology as cancer develops. With lead programs in non-invasive early detection of pancreatic and ovarian cancers in patients at the highest risk for these diseases. Headquartered in the U.S, the company’s CLIA and CAP-accredited laboratory is located in San Diego, Calif., with additional presence in the San Francisco Bay Area and internationally. #biotechnology #epigenomics #oncology #cancerresearch #cancer
-